As diabetes care continues to be a significant focus, promising treatments are appearing . Retatrutide, Tirzepatide, and Semaglutide represent a exciting advancement in GLP-1 receptor agonist medications. https://wisesocialsmedia.com/story7697333/retatrutid-vs-that-medication-vs-semaglutide-a-direct-look